On December 22, 2024, the first BIOV International Summit on Life Technology and Regenerative Medicine, hosted by the AVZ Foundation and BioV Biotech Company, was grandly held in Bangkok, Thailand. This summit gathered top scholars, entrepreneurs, and industry leaders from around the world in the life sciences field, focusing on the latest research results and future development directions in regenerative medicine and life technology. Over a hundred guests participated, including the Thai Royal Prince, Nobel laureate Professor George F. Smoot, Professor Edvard Moser (online), and Professor Thomas C. Sudhof (online).
Speech by the Thai Royal Prince: Highlighting the Importance of International Cooperation
The Thai Royal Prince delivered the opening speech, warmly welcoming professors and guests gathered in Bangkok. He fully affirmed the exploration achievements of the global medical community in the field of regenerative medicine and emphasized the importance of international cooperation in promoting progress in life sciences, hoping that this summit would contribute to global medical endeavors.
AVZ Foundation: Promoting Life Science Innovation through Capital
Ms. Viviana, CEO of the AVZ Foundation, delivered a bilingual opening speech, warmly welcoming the support of the guests on behalf of the AVZ Foundation and BioV Biotech Company. She pointed out that the life sciences field is at the forefront of addressing major human challenges, and the universalization of science and technology is a key goal. The AVZ Foundation has always adhered to an innovation-driven philosophy, connecting global resources through capital to support disruptive technologies and enterprise development. She also announced that the foundation will launch more creative programs related to charity in the future, investing a portion of the revenue into scientific research to contribute to human health.
Professor George F. Smoot: Future Possibilities of Stem Cells
Nobel Prize in Physics laureate and 'Father of Stem Cells' Professor George F. Smoot delivered an academic speech themed 'Automation and Safety of Stem Cell Centers and Treatments'. He analyzed the vast market space for stem cells from a global treatment layout perspective and reviewed the important achievements of stem cell research. He posed a critical question to the attendees: what kind of transformation will stem cells bring in the future? Professor Smoot expressed that it was significant to be present in person before Christmas Eve to share insights with experts and scholars from various fields.
Professor Edvard Moser: Prospects of Cell Research in Treating Alzheimer's Disease
Nobel Prize in Physiology or Medicine laureate Professor Edvard Moser's speech focused on the importance of cell research in treating Alzheimer's disease. He pointed out that Alzheimer's disease is particularly common among the elderly, and research on cellular localization systems has profound significance for overcoming this challenge.
Professor Thomas C. Sudhof: Broad Applications of Stem Cell-Derived Technologies
Nobel Prize in Medicine laureate Professor Thomas C. Sudhof explored the potential of stem cell-derived cells as tools for understanding diseases. He indicated that these technologies may be widely applied in regenerative medicine in the future, providing new pathways to address major health issues in society.
Dr. Yan Ying: Application of TILS Cells in Advanced Colorectal Cancer
Dr. Yan Ying from Fudan University School of Medicine shared groundbreaking progress in the clinical application of TILS cell preparation in advanced colorectal cancer. He detailed three milestone achievements in tumor research, providing new possibilities and perspectives for cell therapy.
Dr. Chen Lin: Ensuring the Safety and Stability of NK Cell Culture
Dr. Chen Lin, a PhD from Boston University and postdoctoral fellow at Harvard University, focused his speech on the application of trophoblast cell methods in NK cell culture. He pointed out that scientific validation shows that NK cells have good safety and no tumorigenic risk, providing a reliable foundation for future cell therapy.
Dr. Shi Lin: Cell Therapy Opens a New Era in Medicine
Dr. Shi Lin from Queen Mary University of London and the Beijing Noseki Genome Research Center stated that the 20th century was the era of drug therapy, while the 21st century is the era of cell therapy. Through numerous examples, he demonstrated the broad prospects of cell therapy in the medical field and defined it as a new star in biomedical research.
Chairman Sun Xin: Constructing the Health Island Concept
Chairman Sun Xin of Zhongjian Group proposed the concept of a 'Health Island', emphasizing the creation of a comprehensive health management system within the BIOV ecosystem through new products and technologies, pioneering new models for human health.
Dr. Ma Lixin: Cell Technology Aids in Curing Chronic Diseases and Malignant Tumors
Dr. Ma Lixin, a medical doctor from Tongji University, summarized the practical cases of BioV Biotech in the clinical cure of chronic diseases and malignant tumors. He emphasized that modern cell technology can not only treat diseases but also prolong life, bringing new breakthroughs to medical research.
Chairman of the AVZ Foundation's Concluding Speech: Conveying Future Beliefs
Finally, Mr. Yu, the chairman of the AVZ Foundation, made a concluding speech. He expressed gratitude for the support of the guests present and conveyed a strong belief in the future of life science development. Mr. Yu stated that the AVZ Foundation will continue to promote international cooperation and contribute to the development of regenerative medicine and life technology.
This summit provided a high-level communication platform for the global life sciences field, further highlighting the important role of the BIOV project in global health.
Author: TechubNews; from the ChainDed Content Open Platform 'Dededehao'. This article only represents the author's views and does not represent the official position of ChainDed. The originality and content authenticity of 'Dededehao' articles are guaranteed by the contributors. If the manuscript leads to legal consequences due to plagiarism, forgery, etc., the contributor is responsible. If there are any infringements, violations, or other inappropriate content, readers are encouraged to supervise. Once confirmed, the platform will immediately take it offline. For issues related to the article's content, please contact WeChat: chaindd123.